Latest updates for Immunotherapy

Fresh curated links around immunotherapy are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • First-Line Immunotherapy for Cancer: How the Treatment Order Is Changing in India
  • Regulatory T cell reprogramming heads to trial in 2026
  • Scientists Advance Precision Cancer Immunotherapy

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

edtimes.in /1 week ago

First-Line Immunotherapy for Cancer: How the Treatment Order Is Changing in India

Mumbai (Maharashtra) [India], October 12: For much of the past two decades, immunotherapy was thought of as a treatment held in reserve — an option to try after chemotherapy and ra...

Read source
kevinmd.com /1 month ago

Regulatory T cell reprogramming heads to trial in 2026

Most people have heard of cancer immunotherapy by now. These treatments help a patient’s own immune system recognize and attack cancer. The best-known examples are immune checkpoin...

Read source
bioengineer.org /1 month ago

Scientists Advance Precision Cancer Immunotherapy

Cancer immunotherapy is entering a more controlled and technically sophisticated phase, according to a wide-ranging collection of studies and reviews that outline how researchers a...

Read source
sciencedaily.com /2 weeks ago

Bowel cancer “melted away” after immunotherapy, then stayed away

A short course of immunotherapy before surgery may offer remarkably durable protection for some patients with stage two or three bowel cancer. In the NEOPRISM-CRC trial, 32 patient...

Read source
scitechdaily.com /1 month ago

“Cancer Melted Away”: Immunotherapy Delivers Striking Results in Bowel Cancer Trial

Pre-surgery immunotherapy kept a group of bowel cancer patients cancer-free for nearly three years, while personalized blood tests helped predict treatment response. Patients with...

Read source
bioengineer.org /1 month ago

Staphylococcal Protein Reprograms Liver Tumor Macrophages to Boost Immunotherapy

One of the most stubborn obstacles in cancer immunotherapy is not the tumor cell itself but the cellular entourage that surrounds it. In hepatocellular carcinoma, the most common f...

Read source
medicalxpress.com /2 weeks ago

Making pediatric cancer more 'visible' boosts immunotherapy response

High-risk neuroblastoma is one of the most aggressive forms of solid tumors affecting children, originating in the nervous system. While a newer class of targeted immunotherapy dru...

Read source
peterattiamd.com /9 hours ago

Personalized medicine comes to cancer immunotherapy

A phase III trial for personalized melanoma vaccination foreshadows a new era of cancer treatment The post Personalized medicine comes to cancer immunotherapy appeared first on Pe...

Read source
bioengineer.org /3 weeks ago

Immune Cells Cluster Around Blood Vessels to Predict Lung Cancer Immunotherapy Success

Immunotherapy has transformed the treatment landscape for non-small cell lung cancer, the most common form of lung malignancy worldwide, yet a stubborn problem persists: only a sub...

Read source
biopharmadive.com /3 weeks ago

ai3Bio, built from two biotechs, pursues a different path to an ‘immune reset’

Rather than deplete malfunctioning B cells as many other emerging autoimmune drugs do, Ai3Bio’s therapies are designed to eliminate a particular group of T helper cells.

Read source
bioengineer.org /1 month ago

Nanoparticles Could Help Radiation Turn Cancer Immunity Into Durable Treatment

Radiotherapy may do more than destroy cancer cells at the site of treatment: it can also alert the immune system to the tumor. Yet that alarm is often too faint, too brief, or too...

Read source
bioengineer.org /2 weeks ago

mRNA Vaccine Paired With Radiotherapy Shrinks HER2-Positive Lung Tumors in Mice

A HER2-targeted mRNA lipid nanoparticle vaccine combined with fractionated radiotherapy suppressed tumor growth and reprogrammed the immune microenvironment in a mouse model of HER...

Read source
medicalxpress.com /1 month ago

Novel immunotherapy leads to complete regression of chemotherapy-resistant liver cancer in 3-year-old

A new report in the New England Journal of Medicine by researchers at Baylor College of Medicine, Texas Children's Hospital and Seattle Children's describes a complete regression o...

Read source
fodmapeveryday.com /1 week ago

Scientists Report Bowel Cancer Tumors Melted Away After Nine Weeks of Immunotherapy

Christopher Burston’s bowel cancer appeared to disappear after just nine weeks of immunotherapy, yet he still underwent surgery. The British patient, diagnosed with stage III bowel...

Read source
medcitynews.com /2 weeks ago

Immunology Startup ai3Bio Aims to Redefine What It Means to Reset the Immune System

While the immune reset field is mainly focused on depleting pathogenic B cells, ai3Bio is applying its novel approach to inflammatory T cells. The startup’s initial disease targets...

Read source
wired.com /1 month ago

‘Smart’ Nanoparticles Deliver mRNA Directly to Tumors in New Cancer Therapy

The treatment can reprogram immune cells that have been corrupted by the cancer, strengthening the body’s ability to attack.

Read source
scitechdaily.com /1 month ago

Cancer’s Hidden Antioxidant Shield Helps It Escape the Immune System

Blocking an antioxidant protein that tumors use to suppress immune attacks improved cancer immunotherapy responses in mice. Cancer cells can release antioxidants that interfere wit...

Read source
biopharmadive.com /1 month ago

North Immunology joins biotech reverse merger boom with Aethlon deal

Armed with $180 million and a dual-acting antibody for eczema, the startup is capitalizing on a change in sentiment that’s led to a sudden spike in reverse merger deals.

Read source
genengnews.com /1 month ago

Chronic Interferon Exposure Linked to Immunosuppression in Cancer

A preclinical study uncovered a novel pathway that links chronic IFN-II exposure to mitochondrial dysfunction and ultimately immunosuppression in cancer, creating foundational insi...

Read source
sciencedaily.com /1 month ago

A cancer therapy put severe rheumatoid arthritis into remission

CAR T-cell therapy dramatically reduced disease activity in six people with severe rheumatoid arthritis that had resisted other treatments, with three achieving medication-free rem...

Read source
scitechdaily.com /1 month ago

Pancreatic Cancer Disappears in Mice After New mRNA Immunotherapy

Pancreatic tumors vanished in roughly half of mice given an experimental mRNA therapy and did not return for up to a year after treatment stopped. Researchers at UMass Chan Medical...

Read source
medcitynews.com /4 days ago

GSK Immunotherapy Gets Accelerated FDA Approval for Treating Rectal Cancer

The GSK cancer immunotherapy Jemperli is now approved for treating advanced cases of rectal cancer harboring a particular genetic signature. It’s a label expansion for Jemperli, wh...

Read source
bioengineer.org /1 month ago

Light-Activated Cancer Therapy Shows Power to Trigger Body-Wide Immune Attack on Tumors

Photodynamic therapy, or PDT, has long been regarded as a precisely local cancer treatment: a photosensitizing drug is delivered to a tumor, light of a specific wavelength activate...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Immunotherapy

feeds.feedburner.com

Recent coverage from public sources
Public source

bioengineer.org

Recent coverage from public sources
Public source

edtimes.in

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

medcitynews.com

Recent coverage from public sources
Public source